Literature DB >> 10589910

Visceral leishmaniasis (kala-azar) in solid organ transplantation: report of five cases and review.

J Hernández-Pérez1, M Yebra-Bango, E Jiménez-Martínez, C Sanz-Moreno, V Cuervas-Mons, L Alonso Pulpón, A Ramos-Martínez, J Fernández-Fernández.   

Abstract

Visceral leishmaniasis is an infectious disease that occurs only rarely in recipients of solid organ grafts but is associated with an elevated mortality rate despite proper treatment. We report five cases diagnosed in our hospital. All the patients were men aged 30 to 60 years who had undergone kidney transplantation (3 patients), heart transplantation (1), or liver transplantation (1). Three of the patients died, one had multiple recurrences, and one developed post-kala-azar cutaneous leishmaniasis. We review the clinical features, treatments, and outcomes of 26 previously reported cases, pointing out the lower cure rate associated with human immunodeficiency virus infection.

Entities:  

Mesh:

Year:  1999        PMID: 10589910     DOI: 10.1086/520457

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  12 in total

Review 1.  Clinical and experimental advances in treatment of visceral leishmaniasis.

Authors:  H W Murray
Journal:  Antimicrob Agents Chemother       Date:  2001-08       Impact factor: 5.191

Review 2.  Parasitic central nervous system infections in immunocompromised hosts: malaria, microsporidiosis, leishmaniasis, and African trypanosomiasis.

Authors:  Melanie Walker; James G Kublin; Joseph R Zunt
Journal:  Clin Infect Dis       Date:  2005-11-23       Impact factor: 9.079

Review 3.  Transmission of tropical and geographically restricted infections during solid-organ transplantation.

Authors:  P Martín-Dávila; J Fortún; R López-Vélez; F Norman; M Montes de Oca; P Zamarrón; M I González; A Moreno; T Pumarola; G Garrido; A Candela; S Moreno
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

4.  Transplantation in the tropics: lessons on prevention and management of tropical infectious diseases.

Authors:  Ligia C Pierrotti; Camille N Kotton
Journal:  Curr Infect Dis Rep       Date:  2015-07       Impact factor: 3.725

5.  Suppression of posttreatment recurrence of experimental visceral Leishmaniasis in T-cell-deficient mice by oral miltefosine.

Authors:  H W Murray
Journal:  Antimicrob Agents Chemother       Date:  2000-11       Impact factor: 5.191

6.  Postrenal transplant laryngeal and visceral leishmaniasis - A case report and review of the literature.

Authors:  P K Jha; M Vankalakunti; V Siddini; K Babu; S H Ballal
Journal:  Indian J Nephrol       Date:  2012-07

7.  Cytomegalovirus and Leishmania donovani coinfection in a renal allograft recipient.

Authors:  N Prasad; A Gupta; R K Sharma; S Gopalakrishnan; V Agrawal; M Jain
Journal:  Indian J Nephrol       Date:  2011-04

8.  Visceral leishmaniasis in 26 HIV-negative adults.

Authors:  Hazar Lahlou; Ahmed B Filali; Meryem Alami; Moncef Amrani; Rhizlane Berrady; Samira Rabhi; Wafaa Bono
Journal:  BMC Res Notes       Date:  2011-10-08

Review 9.  Solid Organ Transplant and Parasitic Diseases: A Review of the Clinical Cases in the Last Two Decades.

Authors:  Silvia Fabiani; Simona Fortunato; Fabrizio Bruschi
Journal:  Pathogens       Date:  2018-07-31

Review 10.  New insights into leishmaniasis in the immunosuppressed.

Authors:  Hannah Akuffo; Carlos Costa; Johan van Griensven; Sakib Burza; Javier Moreno; Mercè Herrero
Journal:  PLoS Negl Trop Dis       Date:  2018-05-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.